Val­ne­va rais­es about €61M; Im­muneer­ing de­tails new Phase 2a da­ta

Plus, news about ONL Ther­a­peu­tics, Cidara Ther­a­peu­tics, Emer­gent BioSo­lu­tions, Vi­co Ther­a­peu­tics and Centes­sa:

Val­ne­va gets €61.2M pri­vate place­ment: Val­ne­va said the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA